Nah Snapiti doesn't have to work if he doesn't want to other than gathering seafood when he feels like it whereas Moosie will be stuck in a museum dusting down sets of antlers for a few more years to come:cool:
Printable View
To be fair though-Snaps did post about how he was concerned about the ''rhetoric'' and was very wary BEFORE the actual sales announcement,so regardless what anyone thinks of him-he did call it that time(or at least was concerned)
Whether his view this time around (or mine, or any ones)is right, is anyone's guess.
(in terms of class of the announcements today--thats already been summed up pretty well)
There will still be some folks out there (not s.t. followers) who are not aware of the correct information regarding the patent. I just checked my ASB Sharetrading account and clicked the box next to PEB in my watch list, and the first announcement comes up re- CX-Blabber! I'm wondering if trades will be reversed due to the stuff-up?
You know the ASB guy on the TV3 news spent a full five minutes tonight telling us about the Cxbladder patent too, but when I reflected he was not incorrect, Pacific Edge have indeed told us the patent is coming, it’s just coming in February next year after all. By the time we all recover from xmas and a failed new year’s resolution or two it will be on the shelf next to the Cxcolorectal patent.
Re: second of three announcements today:
https://www.nzx.com/files/attachments/204523.pdf
Correction on Pacific Edge Limited Patent Issue
Pacific Edge Limited ("the Company") advises the market that it has incorrectly posted the NZX release for the issue of its bladder cancer patent in Europe.
The Company’s bladder cancer patent has not issued however the patent has successfully completed examination and the Company has been advised by the European Patent Office that the patent will issue by February 2015.
The Company wishes to inform the market that Pacific Edge’s colorectal cancer biomarker patent has issued in Europe. Details of this are provided in the Company's separate announcement.
End
Yep, good news is good news. Who knows it may be a tad easier to get sales traction in Liechtenstein, Turkey, Monaco, Iceland, Norway, the Republic of Macedonia,
San Marino, Albania and Serbia. Than the good ole' US of A.
Seriously though, it may very well do so for many of 38 European countries covered, particularly France, Germany, UK etc.
If they enter in one or two year’s time with a hoard of US generated cash to fund it, a healthy US market share as a representation of confidence, any number of further published studies by that time, and of course probably the full suite of four cxbladder products, it may well just pick up quite quickly.
Certainly there is intent to be read into the announcements, I don't think analysts will start to work up a valuation for a European launch until later next year though, would like to be proven wrong though.
Snapiti is currently putting together a good behaviour bond to get out of jail soon.
(He really just can't remember his password because he's getting so old) :D